Co saw good results from across geographies: Erez Israeli, Dr Reddy’s Lab
  • WebDesk BTVI
  • Jul 30 2019

Erez Israeli, CEO & Global Head of Generics Business and PSAI at Dr Reddy’s Laboratories, says the company saw good growth in all business segments except API which led to a good Q1. He says the firm is seeing results from efficiency activities undertaken during Q1 across geographies. On the firm’s India market presence, he says management is very pleased with its performance in Indian market. He says the firm met FDA at the end of May and is currently awaiting inspection.